Wegovy Pill / Oral Semaglutide

W8MD Medication Options

Wegovy Pill / Oral Semaglutide

Oral semaglutide obesity options expand non-injectable choices for selected patients who prefer tablets when appropriate.

Highlights

W8MD pricing and program highlights

Semaglutide programs

$29.99/week+

With insurance accepted for qualifying visits; self-pay from $59.99/week and up.

Tirzepatide programs

$45/week+

With insurance accepted for qualifying visits; self-pay from $69.99/week and up.

Medical program

Personalized

Nutrition, medications, behavior support, sleep evaluation and maintenance.

Pricing, eligibility, insurance coverage, medication coverage, availability and treatment plans vary. W8MD accepts most insurances for qualifying visits.
Overview

Wegovy Pill / Oral Semaglutide: what patients should know

Oral semaglutide obesity options expand non-injectable choices for selected patients who prefer tablets when appropriate.

Modern options

GLP-1 and incretin medications include semaglutide, tirzepatide, oral semaglutide and Foundayo/orforglipron.

Traditional options

Phentermine, phendimetrazine, diethylpropion, Qsymia, Contrave and orlistat remain useful for selected patients.

Safety review

Medication choice depends on medical history, contraindications, cost, coverage and patient preference.

Wegovy Pill / Oral Semaglutide at W8MD
Wegovy Pill / Oral Semaglutide services by W8MD are individualized to the patient and supervised by trained providers.
W8MD approach

How W8MD can help

  • Review BMI, medical history, blood pressure, medications and contraindications.
  • Discuss expected benefits, side effects, cost and insurance coverage.
  • Combine medication with nutrition, activity, sleep and maintenance planning.
Evidence and updates

Helpful authoritative references

W8MD keeps content aligned with current public medical information while individual treatment decisions remain personalized.

FDA Zepbound and OSA

The FDA approved Zepbound for moderate-to-severe obstructive sleep apnea in adults with obesity, with diet and physical activity.

FDA Zepbound OSA update

FDA Wegovy HD

The FDA approved a higher-dose 7.2 mg Wegovy HD option for weight loss and long-term maintenance in certain adult patients.

FDA Wegovy HD update

Home sleep testing

The American Academy of Sleep Medicine describes home sleep apnea testing as an alternative to polysomnography for appropriate uncomplicated adults.

AASM home sleep testing statement

Office information

W8MD active offices

W8MD serves patients in New York City, Brooklyn, New Jersey, Connecticut, Greater Philadelphia, South Jersey, Pennsylvania and Delaware through active Brooklyn and Philadelphia offices, with telemedicine options when clinically appropriate.

Brooklyn / New York City

718-946-5500

W8MD Weight Loss, Sleep & MedSpa
2632 East 21st Street, Suite L3
Brooklyn, NY 11235

Book Brooklyn appointment

Greater Philadelphia

215-676-2334

W8MD Philadelphia
1718 Welsh Road, 2nd Floor, Suite C
Philadelphia, PA 19115

Book Philadelphia appointment

Ready to start with W8MD?

Call Brooklyn / NYC at 718-946-5500 or Philadelphia at 215-676-2334. You can also use the form below. Please do not include sensitive medical information in this form.